151 related articles for article (PubMed ID: 36539400)
1. Pharmacological targeting of the mitochondrial calcium-dependent potassium channel KCa3.1 triggers cell death and reduces tumor growth and metastasis in vivo.
Bachmann M; Rossa A; Varanita T; Fioretti B; Biasutto L; Milenkovic S; Checchetto V; Peruzzo R; Ahmad SA; Patel SH; Lukowski R; Edwards MJ; Ceccarelli M; Gulbins E; Zoratti M; Mattarei A; Szabo I
Cell Death Dis; 2022 Dec; 13(12):1055. PubMed ID: 36539400
[TBL] [Abstract][Full Text] [Related]
2. K
Bonito B; Sauter DR; Schwab A; Djamgoz MB; Novak I
Pflugers Arch; 2016 Nov; 468(11-12):1865-1875. PubMed ID: 27752766
[TBL] [Abstract][Full Text] [Related]
3. Ion channels in control of pancreatic stellate cell migration.
Storck H; Hild B; Schimmelpfennig S; Sargin S; Nielsen N; Zaccagnino A; Budde T; Novak I; Kalthoff H; Schwab A
Oncotarget; 2017 Jan; 8(1):769-784. PubMed ID: 27903970
[TBL] [Abstract][Full Text] [Related]
4. Functional expression of mitochondrial K
Bulk E; Todesca LM; Bachmann M; Szabo I; Rieke M; Schwab A
Pflugers Arch; 2022 Nov; 474(11):1147-1157. PubMed ID: 36152073
[TBL] [Abstract][Full Text] [Related]
5. K
Pang ZD; Wang Y; Wang XJ; She G; Ma XZ; Song Z; Zhao LM; Wang HF; Lai BC; Gou W; Du XJ; Deng XL
FASEB J; 2019 Dec; 33(12):14760-14771. PubMed ID: 31690106
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of vascular calcification by block of intermediate conductance calcium-activated potassium channels with TRAM-34.
Freise C; Querfeld U
Pharmacol Res; 2014 Jul; 85():6-14. PubMed ID: 24813858
[TBL] [Abstract][Full Text] [Related]
7. The role and mechanism of K
Ma XZ; Pang ZD; Wang JH; Song Z; Zhao LM; Du XJ; Deng XL
Exp Cell Res; 2018 Aug; 369(2):208-217. PubMed ID: 29792849
[TBL] [Abstract][Full Text] [Related]
8. Intermediate conductance Ca2+-activated potassium channel (KCa3.1) in the inner mitochondrial membrane of human colon cancer cells.
De Marchi U; Sassi N; Fioretti B; Catacuzzeno L; Cereghetti GM; Szabò I; Zoratti M
Cell Calcium; 2009 May; 45(5):509-16. PubMed ID: 19406468
[TBL] [Abstract][Full Text] [Related]
9. Calcium-dependent potassium channels control proliferation of cardiac progenitor cells and bone marrow-derived mesenchymal stem cells.
Vigneault P; Naud P; Qi X; Xiao J; Villeneuve L; Davis DR; Nattel S
J Physiol; 2018 Jun; 596(12):2359-2379. PubMed ID: 29574723
[TBL] [Abstract][Full Text] [Related]
10. Effects of Intermediate-Conductance Ca(2+)-Activated K(+) Channels on Human Endometrial Carcinoma Cells.
Zhang Y; Feng Y; Chen L; Zhu J
Cell Biochem Biophys; 2015 Jun; 72(2):515-25. PubMed ID: 25608633
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and cellular effects of a mitochondria-targeted inhibitor of the two-pore potassium channel TASK-3.
Bachmann M; Rossa A; Antoniazzi G; Biasutto L; Carrer A; Campagnaro M; Leanza L; Gonczi M; Csernoch L; Paradisi C; Mattarei A; Zoratti M; Szabo I
Pharmacol Res; 2021 Feb; 164():105326. PubMed ID: 33338625
[TBL] [Abstract][Full Text] [Related]
12. K⁺-channel inhibition reduces portal perfusion pressure in fibrotic rats and fibrosis associated characteristics of hepatic stellate cells.
Freise C; Heldwein S; Erben U; Hoyer J; Köhler R; Jöhrens K; Patsenker E; Ruehl M; Seehofer D; Stickel F; Somasundaram R
Liver Int; 2015 Apr; 35(4):1244-52. PubMed ID: 25212242
[TBL] [Abstract][Full Text] [Related]
13. Identification of KCa3.1 Channel as a Novel Regulator of Oxidative Phosphorylation in a Subset of Pancreatic Carcinoma Cell Lines.
Kovalenko I; Glasauer A; Schöckel L; Sauter DR; Ehrmann A; Sohler F; Hägebarth A; Novak I; Christian S
PLoS One; 2016; 11(8):e0160658. PubMed ID: 27494181
[TBL] [Abstract][Full Text] [Related]
14. The calcium-activated potassium channel KCa3.1 plays a central role in the chemotactic response of mammalian neutrophils.
Henríquez C; Riquelme TT; Vera D; Julio-Kalajzić F; Ehrenfeld P; Melvin JE; Figueroa CD; Sarmiento J; Flores CA
Acta Physiol (Oxf); 2016 Jan; 216(1):132-45. PubMed ID: 26138196
[TBL] [Abstract][Full Text] [Related]
15. KCa3.1 Channels and Glioblastoma: In Vitro Studies.
Klumpp L; Sezgin EC; Skardelly M; Eckert F; Huber SM
Curr Neuropharmacol; 2018; 16(5):627-635. PubMed ID: 28786347
[TBL] [Abstract][Full Text] [Related]
16. High glucose induces CCL20 in proximal tubular cells via activation of the KCa3.1 channel.
Huang C; Pollock CA; Chen XM
PLoS One; 2014; 9(4):e95173. PubMed ID: 24733189
[TBL] [Abstract][Full Text] [Related]
17. Novel phenolic inhibitors of small/intermediate-conductance Ca²⁺-activated K⁺ channels, KCa3.1 and KCa2.3.
Oliván-Viguera A; Valero MS; Murillo MD; Wulff H; García-Otín AL; Arbonés-Mainar JM; Köhler R
PLoS One; 2013; 8(3):e58614. PubMed ID: 23516517
[TBL] [Abstract][Full Text] [Related]
18. K
Robles-Martínez L; Garay E; Martel-Gallegos MG; Cisneros-Mejorado A; Pérez-Montiel D; Lara A; Arellano RO
Sci Rep; 2017 Jun; 7(1):4340. PubMed ID: 28659615
[TBL] [Abstract][Full Text] [Related]
19. The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to atherogenesis in mice and humans.
Toyama K; Wulff H; Chandy KG; Azam P; Raman G; Saito T; Fujiwara Y; Mattson DL; Das S; Melvin JE; Pratt PF; Hatoum OA; Gutterman DD; Harder DR; Miura H
J Clin Invest; 2008 Sep; 118(9):3025-37. PubMed ID: 18688283
[TBL] [Abstract][Full Text] [Related]
20. PKA reduces the rat and human KCa3.1 current, CaM binding, and Ca2+ signaling, which requires Ser332/334 in the CaM-binding C terminus.
Wong R; Schlichter LC
J Neurosci; 2014 Oct; 34(40):13371-83. PubMed ID: 25274816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
